Gilead Sciences Inc GILD

Healthcare Biotechnology

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.

NDAQ:GILD - Post by User

Gilead Sciences Inc

Bullboard Posts

Post by coffeygon Nov 15, 2012 11:26am

251 Views

Post# 20604628

Can GILD Keep There Promise? I Want The Truth!

I found a Market Option Sale (Planned) made by company Lead Independent Director of Gilead Sciences, , GILD. On 11/15/2012, at stock price US$71.28. Disclose date: -. Gilead Sciences, , GILD - 100 have gone up 100% last 11/15/2012 to US$71.30. Symantec Corporation traded 7789190 million shares in the last trading session, well above its daily average. Academic studies have shown that insiders traditionally make higher investment returns than ordinary investors. Want to find out how they do it? Get the Full Disclosed Report @:

https://pennystocksupdate.biz/free/?code=GILD

Bullboard Posts

Calibre discovers significant gold in Newfoundland